SCTL(Delisted)
Societal CDMOยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SCTL
Societal Cdmo, Inc.
A company that develops a wide range of therapeutic dosage forms with a primary focus on the area of small molecules
1 E. Uwchlan Ave, Suite 112, Exton, Pennsylvania 19341
--
Societal CDMO, Inc., incorporated in Pennsylvania on November 15, 2007, is a bilateral contract development and manufacturing organization (CDMO) with capabilities ranging from pre-investigational new drug development to commercial manufacturing and packaging of a variety of therapeutic dosage forms, focusing primarily on the small molecule region. Societal CDMO, with expertise in solving complex manufacturing problems, is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic filling/completion, freeze-drying, packaging and logistics services to the global pharmaceutical market.
Company Financials
EPS
SCTL has released its 2023 Q3 earnings. EPS was reported at -0.05, versus the expected -0.02, missing expectations. The chart below visualizes how SCTL has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SCTL has released its 2023 Q4 earnings report, with revenue of 27.72M, reflecting a YoY change of 14.17%, and net profit of -786.00K, showing a YoY change of 91.43%. The Sankey diagram below clearly presents SCTL's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
